There are no approved pharmacological treatments for biliary atresia, which is the leading cause of paediatric liver transplant.
China is rapidly overtaking the US in global oncology clinical trials, accounting for more than half of late-stage study activity by 2025.
J&J's MonumenTAL-6 results add to the growing body of evidence touting Talvey and Tecvayli’s use in earlier multiple myeloma treatment lines.
Eli Lilly is set for another win in the glucagon-like peptide-1 (GLP-1) sector as its triple-g agonist, retatrutide, has succeeded in type 2 diabetes and obesity. Marking the four ...
Participants in SHASTA-3 and SHASTA-4 received 25mg of plozasiran via subcutaneous injection every three months. Credit: YURIMA / Shutterstock.com. Arrowhead Pharmaceuticals has reported top line ...
The funds will help Crystalys progress its clinical-stage development efforts and commercialisation plans for its gout drug, dotinurad.
Celldex is discontinuing its Phase II study on barzolvolimab in prurigo nodularis. Credit: ychornobryvets / Shutterstock.com. Celldex’s subcutaneous monoclonal antibody (mAb) has failed to show ...
The study examines the safety, tolerability, and preliminary anti-tumour activity of IPH4502 in Nectin-4 expressing tumours. Credit: Gorodenkoff / Shutterstock.com. French company Innate Pharma has ...
Devonian Health Group has received authorisation from Health Canada for its CTA to begin a Phase II/III study of Thykamine cream to treat mild-to-moderate atopic dermatitis in paediatric patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results